Bolt Biotherapeutics Inc. (BOLT)
NASDAQ
Bolt Biotherapeutics Inc. Operating Income 2020–2025
Bolt Biotherapeutics Inc. annual/quarterly operating income history and growth rate from 2020 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Bolt Biotherapeutics Inc. operating income for the quarter ending March 31, 2026 was -7.6 M, a 37.26% decrease year-over-year.
- Bolt Biotherapeutics Inc. operating income for the twelve months ending March 31, 2026 was -36.6 M, a 50.71% decrease year-over-year.
- Bolt Biotherapeutics Inc. annual operating income for 2025 was -36.1 M, a 50.56% decrease from 2024.
- Bolt Biotherapeutics Inc. annual operating income for 2024 was -73.0 M, a 4.13% decrease from 2023.
- Bolt Biotherapeutics Inc. annual operating income for 2023 was -76.2 M, a 15.64% decrease from 2022.
- Bolt Biotherapeutics Inc. annual operating income for 2022 was -90.3 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Bolt Biotherapeutics Inc. Operating Income — FAQ
Bolt Biotherapeutics Inc. (BOLT) operating income over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Bolt Biotherapeutics Inc.'s operating income?
Bolt Biotherapeutics Inc. (BOLT) reported operating income of -$36M for fiscal 2025.
Where can I see BOLT's operating income history?
The chart and table above show Bolt Biotherapeutics Inc.'s operating income by year and by quarter, including the growth rate.